Savvion® and Patni Life Sciences announced today a strategic partnership to jointly deliver Business Process Management (BPM)-enabled solutions for clinical operations on top of Savvion’s Life Sciences Foundation. Savvion and Patni will apply their expertise and experience to help pharmaceutical, medical device, biotech, and Clinical Research Organizations (CRO) meet the unique business, regulatory, and information technology challenges they face across the drug development life cycle.
Expediting the complex, global regulatory process governing drug trials is a major challenge for life sciences firms. A major obstacle is how to reduce the time to get new drugs to the market while still maintaining the highest quality standards. The partnership between Savvion and Patni meets this challenge by combining Patni’s decades of experience in IT and scientific consulting with Savvion’s fourteen years of experience in optimizing and automating business processes. The outcome of the partnership will help life sciences organizations streamline their drug development and clinical trial operations—all while leveraging their existing information technology infrastructure investments. By optimizing the drug development life cycle, customers will be able to lower the time and cost of delivering compliant, safe, and reliable drugs to the marketplace.
This partnership signifies Savvion’s commitment to this market segment, where the company offers targeted Savvion’s “BPM-enabled” applications that allow you to model, simulate, optimize and execute various collaborative clinical operational processes built on top of its robust and proven BPM platform and Life Sciences Foundation. Patni chose to partner with Savvion because of Savvion’s support for security and life sciences standards as well as the open architecture, frameworks, and business accelerators that are life science industry specific for quick ROI and deployment of clinical operations solutions.